GSV Capital Corp. Reports Second Quarter 2017 Financial Results
Aug 08, 2017 20:06 pm UTC| Business
Net Asset Value of $9.11 per Share as of June 30, 2017 Board of Directors Approves $5.0 Million Share Repurchase Program WOODSIDE, Calif., Aug. 08, 2017 -- GSV Capital Corp. (“GSV Capital” or the “Company”)...
Stewardship Financial Corporation Announces Earnings For The Second Quarter of 2017
Aug 08, 2017 20:06 pm UTC| Business
MIDLAND PARK, N.J. , Aug. 08, 2017 -- Stewardship Financial Corporation (NASDAQ:SSFN), parent company of Atlantic Stewardship Bank, announced net income for the three and six months ended June 30, 2017 of $1.3 million...
Almost Family Reports Second Quarter and Year to Date 2017 Results
Aug 08, 2017 20:06 pm UTC| Business
LOUISVILLE, Ky., Aug. 08, 2017 -- Almost Family, Inc. (NASDAQ:AFAM), a leading national provider of home health and related services, announced today its financial results for the quarter ended June 30, 2017. Second...
Monster Beverage Reports 2017 Second Quarter Financial Results
Aug 08, 2017 20:06 pm UTC| Business
-- Second Quarter Net Sales Rise 9.6 percent to $907.1 million ---- Second Quarter Gross Sales Top $1.0 billion ---- Second Quarter Net Income Increases 20.9 percent to $222.6 million ---- Second Quarter Net Income per...
Novavax Reports Second Quarter 2017 Financial Results
Aug 08, 2017 20:06 pm UTC| Business
GAITHERSBURG, Md., Aug. 08, 2017 -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017. Second Quarter and Subsequent Achievements: Novavax’...
Tucows Reports Continuing Strong Financial Results for Second Quarter of 2017
Aug 08, 2017 20:06 pm UTC| Business
TORONTO, Aug. 08, 2017 -- Tucows Inc. (NASDAQ:TCX) (TSX:TC), a provider of network access, domain names and other Internet services, today reported its financial results for the second quarter ended June 30, 2017. All...
REGENXBIO Reports Second Quarter 2017 Financial Results and Recent Operational Highlights
Aug 08, 2017 20:06 pm UTC| Business
Enrollment continues in RGX-314 Phase I clinical trial for wet AMD; interim update anticipated by year-end 2017Enrollment continues in RGX-501 Phase I/II clinical trial for HoFH; interim update anticipated by year-end...